Nutritional High International Inc. (the “Company” or “Nutritional High”) (CNSX:EAT.CN) (OTCQB:SPLIF) (FRANKFURT:2NU) is pleased to provide an update on its previously announced partnership with NeutriSci International Inc. (“NeutriSci”) (TSXV:NU.VN) (OTCQB:NRXCF) (FRANKFURT:1N9) (see press release dated May 30, 2018).
As of July 11, 2018, NeutriSci and Nutritional High will commence the production process of its newly developed chewable, sublingual THC product (“Nu Energy Tablets”) for sale and distribution in the state of California. The Nu Energy Tablets will be produced at the Company’s Pasa Verde manufacturing facility, located in Sacramento, California. Delivery of the first purchase orders is on track and set to begin in Q3 of 2018. Initial distribution will begin in approximately 400 dispensaries across the state.
The recreational use cannabis market in California is expected to exceed $5 billion in 2019. By comparison, beer sales in California hit $5 billion in 2018, according to industry research group IBIS World.
Jim Frazier, CEO of Nutritional High commented: “We are pleased to announce this milestone in our working relationship with NeutriSci and look forward to rolling out the distribution of the product across California. As a Company, we strive to provide our customers with unique best-in-class cannabis products, and this signifies the continuance of that strategy.”
NeutriSci’s CEO, Glen Rehman stated, “We are very pleased to announce that the manufacturing of the new sublingual melts using NeutriSci’s patent pending CRYOLISATION(TM) technology will begin July 11, 2018. This signifies a major step forward in gaining a strong foot-hold in the California market for both companies. Our partnership with Nutritional High has secured distribution for our ground-breaking product in dispensaries across the state of California. We are excited to bring our product to the California marketplace!”
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
The Company follows a vertically integrated model with a fully developed strategy for acquisitions in extraction, production, sales, and distribution sectors of the cannabis industry. Nutritional High has brought its flagship FLI(TM) edibles and extracts product line from production to market in California through its wholly owned distributor Calyx Brands Inc., and Colorado where its products are manufactured by a licensed producer. The Company also owns a 50% interest in The Clinic Effingham (an Illinois dispensary), and is entering the Nevada, Washington State, Oregon and Canadian markets in the near future.
For updates on the Company’s activities and highlights of the Company’s press releases and other media coverage, please follow Nutritional High on Facebook, Twitter, Instagramand Google+ or visit www.nutritionalhigh.com.
About NeutriSci International Inc.
NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy(R), the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries.
Neuenergy(R) contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine and is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. To find out more about neuenergy(R), please visit www.getneuenergy.com.
For more information, please visit: www.neutrisci.com.
For further information, please contact:
Chairman of the Board
Nutritional High International Inc.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release contains forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such statements include submission of the relevant documentation within the required timeframe and to the satisfaction of the relevant regulators, completing the acquisition of the applicable real estate and raising sufficient financing to complete the Company’s business strategy. There is no certainty that any of these events will occur. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimated”, “forecasts”, “intends”, “anticipates” or “does not anticipate:, “believes”, “may have implications” or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, or “will be taken”, “occur”, or “be achieved”.
Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulation S under the U.S. Securities Act, absent registration, or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.
<img src=”http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzczMjUyMDk=” alt=”” width=”1″ height=”1″/>